Plain-English translation of NCT07347041 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing whether injecting triamcinolone acetonide (a steroid medication) into tight, painful spots in muscles around the hip works just as well as injecting it directly into the hip joint itself for people with hip arthritis. Researchers will compare how well each approach reduces pain and improves quality of life over 2 years. The goal is to find out if the muscle injection method could be a simpler, safer option for patients whose pain hasn't improved with other treatments.
Hip arthritis causes significant pain and disability, especially in older adults, and many people don't get enough relief from conservative treatments like medication and physical therapy. Studies suggest this medication might work well when injected into painful muscle trigger points, which could be easier and safer than injecting directly into the joint—but we need a rigorous comparison to know for sure.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to receive either a steroid injection into trigger points in your hip muscles or directly into your hip joint. After your injection, you'll visit the clinic at 2 weeks, 4 weeks, 8 weeks, 12 weeks, and 24 weeks to report your pain levels and how you're doing overall. The study continues for 2 years total, with researchers tracking your pain scores and any side effects to compare how well each treatment works.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
China